256 related articles for article (PubMed ID: 7969117)
1. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
Dailey L; Yuan H; Basilico C
Mol Cell Biol; 1994 Dec; 14(12):7758-69. PubMed ID: 7969117
[TBL] [Abstract][Full Text] [Related]
2. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Yuan H; Corbi N; Basilico C; Dailey L
Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Ambrosetti DC; Basilico C; Dailey L
Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
[TBL] [Abstract][Full Text] [Related]
4. Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements located in the FGF-4 gene.
Lickteig K; Lamb K; Brigman K; Rizzino A
Mol Reprod Dev; 1996 Jun; 44(2):146-52. PubMed ID: 9115711
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.
Ambrosetti DC; Schöler HR; Dailey L; Basilico C
J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome.
Luster TA; Rizzino A
Gene; 2003 Dec; 323():163-72. PubMed ID: 14659890
[TBL] [Abstract][Full Text] [Related]
7. Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene.
Lamb K; Rosfjord E; Brigman K; Rizzino A
Mol Reprod Dev; 1996 Aug; 44(4):460-71. PubMed ID: 8844688
[TBL] [Abstract][Full Text] [Related]
8. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells.
Hasan S; Koda T; Kakinuma M
J Biol Chem; 1994 Oct; 269(40):25042-8. PubMed ID: 7929190
[TBL] [Abstract][Full Text] [Related]
9. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.
Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A
J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456
[TBL] [Abstract][Full Text] [Related]
10. Effects of three Sp1 motifs on the transcription of the FGF-4 gene.
Luster TA; Johnson LR; Nowling TK; Lamb KA; Philipsen S; Rizzino A
Mol Reprod Dev; 2000 Sep; 57(1):4-15. PubMed ID: 10954851
[TBL] [Abstract][Full Text] [Related]
11. Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.
Lamb KA; Rizzino A
Mol Reprod Dev; 1998 Oct; 51(2):218-24. PubMed ID: 9740330
[TBL] [Abstract][Full Text] [Related]
12. An octamer-binding site is crucial for the activity of an enhancer active at the embryonic met-/mesencephalic junction.
Mihailescu D; Küry P; Monard D
Mech Dev; 1999 Jun; 84(1-2):55-67. PubMed ID: 10473120
[TBL] [Abstract][Full Text] [Related]
13. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
[TBL] [Abstract][Full Text] [Related]
14. Regulation of FGF-4 enhancer activity by transcription factor NF-Y.
Bryans M; Lucas JM; Knobloch TJ; Wilkie NM; Lang JC
Biochem Biophys Res Commun; 1995 Jun; 211(2):519-27. PubMed ID: 7794264
[TBL] [Abstract][Full Text] [Related]
15. Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box.
Boer B; Luster TA; Bernadt C; Rizzino A
Mol Reprod Dev; 2005 Jul; 71(3):263-74. PubMed ID: 15803454
[TBL] [Abstract][Full Text] [Related]
16. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
de Anta JM; Monzó M; Peris B; Ruano D
Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
[TBL] [Abstract][Full Text] [Related]
17. Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.
Curatola AM; Basilico C
Mol Cell Biol; 1990 Jun; 10(6):2475-84. PubMed ID: 2188089
[TBL] [Abstract][Full Text] [Related]
18. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells.
Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A
Mol Reprod Dev; 1998 Aug; 50(4):377-86. PubMed ID: 9669521
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Sox-2 inhibits co-activator stimulated transcription.
Bernadt CT; Nowling T; Rizzino A
Mol Reprod Dev; 2004 Nov; 69(3):260-7. PubMed ID: 15349837
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors.
Tverberg LA; Russo AF
J Biol Chem; 1993 Jul; 268(21):15965-73. PubMed ID: 8340417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
